Novavax (NVAX) News Today

$13.01
-1.39 (-9.65%)
(As of 05/17/2024 ET)
Novavax (NASDAQ:NVAX) Trading Down 8.8%
Is Novavax Stock a Buy?
Novavax (NASDAQ:NVAX) Stock Price Down 8.8%
Novavax (NASDAQ:NVAX) Stock Price Down 8.8%
Could Novavax Become the Next Moderna?
Novavax (NASDAQ:NVAX) Shares Up 12.4%
Novavax (NASDAQ:NVAX) Shares Up 12.4%
Brokerages Set Novavax, Inc. (NASDAQ:NVAX) Price Target at $14.00
Novavax (NASDAQ:NVAX) Shares Gap Down to $13.48
Novavax (NASDAQ:NVAX) Shares Gap Down to $13.48
Novavax (NASDAQ:NVAX) PT Raised to $10.00
Novavax (NASDAQ:NVAX) Sees Large Volume Increase on Analyst Upgrade
Novavax (NASDAQ:NVAX) Sees Large Volume Increase After Analyst Upgrade
3 Cheap Biotech Stocks to Buy Now: May 2024
5 Meme Stocks With a High Short Interest
No, it's not 2021. But waking up today, you might have been forgiven for thinking so.
5 Meme Stocks With a High Short Interest (NVAX)
Keith Gill, aka RoaringKitty, resurfaces on Twitter, triggering a surge in GameStop and AMC Entertainment shares amid remarkable trading volume.
Novavax (NASDAQ:NVAX) Upgraded at Bank of America
Novavax (NASDAQ:NVAX) Shares Gap Up on Analyst Upgrade
Novavax (NASDAQ:NVAX) Shares Gap Up Following Analyst Upgrade
Novavax (NASDAQ:NVAX) Shares Gap Up Following Analyst Upgrade
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Analysts
Shares of Novavax, Inc. (NASDAQ:NVAX - Get Free Report) have been assigned an average recommendation of "Hold" from the five ratings firms that are presently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and two have issued a buy rec
Novavax (NASDAQ:NVAX) Price Target Raised to $10.00
TD Cowen lifted their price target on shares of Novavax from $5.00 to $10.00 and gave the company a "hold" rating in a research report on Monday.
HC Wainwright Reiterates "Buy" Rating for Novavax (NASDAQ:NVAX)
HC Wainwright reissued a "buy" rating and issued a $19.00 target price on shares of Novavax in a report on Monday.
Novavax (NASDAQ:NVAX) Posts Earnings Results
Novavax (NASDAQ:NVAX) Reaches New 12-Month High at $11.00
Novavax (NASDAQ:NVAX) Issues Quarterly Earnings Results
Novavax (NASDAQ:NVAX - Get Free Report) announced its quarterly earnings results on Friday. The biopharmaceutical company reported ($1.05) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.04) by ($0.01). The firm had revenue of $93.90 million for the quarter, compared to analyst estimates of $71.32 million. During the same period in the prior year, the company earned ($3.41) EPS. Novavax's revenue was up 15.9% on a year-over-year basis.
Novavax (NASDAQ:NVAX) Hits New 1-Year High at $11.00
Novavax (NASDAQ:NVAX) Reaches New 12-Month High at $11.00
Novavax (NASDAQ:NVAX) Stock Rating Upgraded by Bank of America
Bank of America raised shares of Novavax from an "underperform" rating to a "neutral" rating and boosted their price target for the company from $4.00 to $12.00 in a report on Friday.
Get Novavax News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter.

Free report reveals “two-baggers” for 2024 (Ad)

We’ve put together something special for our subscribers — a free report on 5 stocks we believe could double in 2024. It’s straightforward, easy to understand, and most importantly, actionable.

Download your free report today!

NVAX Media Mentions By Week

NVAX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NVAX
News Sentiment

0.52

0.42

Average
Medical
News Sentiment

NVAX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NVAX Articles
This Week

41

9

NVAX Articles
Average Week

Get Novavax News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:NVAX) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners